NeuroOne Medical Technologies Corporation
NMTC · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $12,098 | $3,453 | $1,952 | $171 |
| % Growth | 250.4% | 76.9% | 1,040.7% | – |
| Cost of Goods Sold | $3,956 | $2,373 | $1,496 | $242 |
| Gross Profit | $8,141 | $1,080 | $457 | -$71 |
| % Margin | 67.3% | 31.3% | 23.4% | -41.4% |
| R&D Expenses | $4,983 | $5,065 | $6,941 | $4,929 |
| G&A Expenses | $0 | $7,793 | $6,753 | $6,709 |
| SG&A Expenses | $7,385 | $7,902 | $6,926 | $6,979 |
| Sales & Mktg Exp. | $0 | $109 | $173 | $271 |
| Other Operating Expenses | $0 | $0 | -$1,455 | -$1,949 |
| Operating Expenses | $12,368 | $12,967 | $12,412 | $9,960 |
| Operating Income | -$4,226 | -$11,887 | -$11,955 | -$10,031 |
| % Margin | -34.9% | -344.3% | -612.3% | -5,860.2% |
| Other Income/Exp. Net | $621 | -$431 | $96 | $31 |
| Pre-Tax Income | -$3,605 | -$12,318 | -$11,859 | -$10,000 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,605 | -$12,318 | -$11,859 | -$10,000 |
| % Margin | -29.8% | -356.7% | -607.4% | -5,842% |
| EPS | -0.09 | -0.46 | -0.65 | -0.63 |
| % Growth | 80.4% | 29.2% | -3.2% | – |
| EPS Diluted | -0.09 | -0.46 | -0.65 | -0.63 |
| Weighted Avg Shares Out | 40,153 | 26,762 | 18,121 | 15,999 |
| Weighted Avg Shares Out Dil | 40,153 | 26,762 | 18,121 | 15,999 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $229 | $0 | $0 |
| Depreciation & Amortization | $262 | $247 | $199 | $119 |
| EBITDA | -$3,010 | -$11,842 | -$11,756 | -$9,912 |
| % Margin | -24.9% | -343% | -602.1% | -5,790.9% |